glp-1 microdosing Microdosing GLP-1s: Risks & Considerations

Gutierrez, MD, a board-certified endocrinologist who is an associate professor of endocrinology, diabetes, and metabolism at McGovern Medical School in Houston

What berberine may reasonably do A fair statement would be: Berberine may modestly improve some metabolic markers in some people

The link between the medications and cancer risk could be due to weight loss, since having overweight or obesity is linked to a higher cancer rate, or it could be from the impact GLP-1s have on certain pathways in the body

As with any drug, however, the one that will be most effective for your body will depend on your lifestyle, your genetics, and your environment

[DOI] [PMC free article] [PubMed] 35.Jennifer P., Patrick C., Danny I., Ronald T., Jennifer D., Anders W., Rahul K., Lorenzo O., Firas B., Vahagn A., et al

Safety, tolerability, pharmacokinetics, and pharmacodynamics of a novel oral small molecule GLP-1 receptor agonist (HRS-7535) in healthy subjects a phase 1, randomized, double-blind, placebo-controlled, single- and multiple-ascending dose study